Littlejohn & Co, the New England‑based private equity firm founded in 1996, elevated former associate Charles Leung to managing director on Tuesday. Leung began with the firm in 2013 and has since built a reputation for sourcing growth‑capital deals across technology and healthcare. His promotion signals a shift toward deeper expertise in mid‑market transactions.

Beyond Littlejohn, Leung sits on the boards of Ardurra, GDS Associates and Milrose Consultants, all headquartered in Greenwich, Connecticut. These appointments give him insight into complementary advisory services that feed the firm’s deal pipeline. The move also consolidates Littlejohn’s leadership bench, positioning the firm to capture emerging opportunities in the regional investment landscape.

Leung’s elevation follows a period of steady growth for Littlejohn, which recently closed several multi‑million‑dollar transactions in tech and healthcare. By promoting an internal talent with a strong board presence, the firm signals confidence in its organic development strategy. Investors will watch how his leadership shapes future deal flow and valuation dynamics in the mid‑market segment.

Industry analysts note that Littlejohn’s focus on mid‑market deals aligns with a broader trend of larger funds shifting toward niche opportunities. Leung’s board roles provide cross‑industry insights that could accelerate sourcing of high‑growth assets. The promotion may also attract talent seeking clear advancement paths within boutique firms, reinforcing Littlejohn’s competitive edge in a crowded PE landscape.